Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Resistance and Microbiome in Children (ARMCA)
NCT03187834Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of azithromycin, amoxicillin, trimethoprim + sulfamethoxazole in bacterial infection, sponsored by University of California, San Francisco. Started Jul 2017; status: completed.
02
Drugs
azithromycinamoxicillintrimethoprim + sulfamethoxazole
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03187834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187834.